Halozyme Therapeutics Inc (NASDAQ:HALO)

18.86
Delayed Data
As of 4:00pm ET
 -0.30 / -1.57%
Today’s Change
11.41
Today|||52-Week Range
21.48
-6.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash61.4M43.3M66.8M153.0M
 
 
 
 
 
Short Term Investment Cash34.0M-18.1M23.5M102.0M
 
 
 
 
 
Cash & Short Term Investments135.6M108.3M205.0M469.2M
 
 
 
 
 
 
ReceivablesReceivables9.1M32.4M15.7M22.1M
 
 
 
 
 
 
InventoriesInventories6.4M9.5M14.6M5.1M
 
 
 
 
 
 
Current AssetsOther Current Assets10.1M21.5M21.2M13.9M
 
 
 
 
 
Current Assets161.3M171.8M256.5M510.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross12.2M14.3M16.2M17.4M
 
 
 
 
 
Depreciation-9.2M-10.3M-11.9M-13.9M
 
 
 
 
 
Other Assets1.2M5.6M219.0K5.6M
 
 
 
 
 
Total Assets166.0M181.8M261.5M519.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.0M4.5M3.6M7.9M
 
 
 
 
 
Short Term Debt0.0021.9M17.4M77.2M
 
 
 
 
Accrued Expenses8.0M15.0M17.3M25.8M
 
 
 
 
 
Other Current Liabilities15.4M27.5M22.1M32.8M
 
 
 
 
 
Other Liabilities24.3M62.5M54.6M131.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt49.9M28.0M199.2M125.1M
 
 
 
 
 
Other Liabilities3.2M4.4M358.0K814.0K
 
 
 
 
 
Total Liabilities124.6M138.8M294.0M311.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity41.4M43.0M-32.5M208.4M
 
 
 
 
 
Total Shareholder Equity41.4M43.0M-32.5M208.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding125.7M128.2M129.5M142.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.